{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:58:26Z","timestamp":1794808706202,"version":"4.9.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The progression of hepatocellular carcinoma (HCC) is intricately linked to complex interactions within the tumor microenvironment (TME), where the reprogramming of tumor-associated macrophages (TAMs) plays a pivotal role. However, how HCC cells regulate TAM metabolism and function via extracellular vesicles, such as exosomes, remains incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We isolated exosomes from HCC cell lines and co-cultured them with macrophages. Using proteomics, lipid analysis, flow cytometry, and animal models, we evaluated the effects of exosomal FABP5 on macrophage polarization and lipid metabolism. The role of FABP5 in tumor progression was assessed via\n                      <jats:italic>in vivo<\/jats:italic>\n                      experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study reveals that HCC cells release fatty acid-binding protein 5 (FABP5) via exosomes, transferring it to TAMs, thereby inducing significant lipid metabolism reprogramming in macrophages. Mechanistically, exosomal FABP5 promotes lipid accumulation by activating the PPAR\u03b3 signaling pathway, while potentially inhibiting the PPAR\u03b1 signaling pathway to reduce fatty acid oxidation, ultimately driving TAM polarization towards an M2 phenotype, characterized by increased secretion of immunosuppressive cytokines and a pro-tumor phenotype. Clinical data analysis indicates that high FABP5 expression in HCC tissues correlates with poor patient prognosis. In liver-specific FABP5 knockout mouse models and HCC xenograft models, FABP5 deletion significantly suppressed tumor growth, reduced M2-type TAM infiltration and lipid accumulation, and enhanced anti-tumor immune responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings collectively uncover exosomal FABP5 as a key mediator of metabolic and immune communication between HCC and TAMs, promoting HCC progression by remodeling the tumor immune microenvironment, and suggest FABP5 as a potential therapeutic target for HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1644645","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:35:54Z","timestamp":1758000954000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Exosomal FABP5 drives HCC progression via macrophage lipid metabolism and immune microenvironment remodeling"],"prefix":"10.3389","volume":"16","author":[{"given":"Siyi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.01.031","article-title":"Tumor-associated macrophages","volume":"30","author":"Cassetta","year":"2020","journal-title":"Curr Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: From mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7150\/ijbs.8879","article-title":"Macrophage polarization in inflammatory diseases","volume":"10","author":"Liu","year":"2014","journal-title":"Int J Biol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting tumor-associated macrophages in cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.04.004","article-title":"Exosomes in cancer development, metastasis, and immunity","volume":"1871","author":"Zhang","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.940056","article-title":"Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma","volume":"12","author":"Zelli","year":"2022","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0739-0","article-title":"Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression","volume":"12","author":"Wu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","article-title":"Macrophage immunometabolism: where are we (Going)","volume":"38","author":"Van den Bossche","year":"2017","journal-title":"Trends Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.09.029","article-title":"FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity","volume":"82","author":"Yang","year":"2025","journal-title":"J Hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s42003-025-07754-0","article-title":"FABP5 is a key player in metabolic modulation and NF-\u03baB dependent inflammation driving pleural mesothelioma","volume":"8","author":"Vecchio","year":"2025","journal-title":"Commun Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-025-03857-6","article-title":"USP14 targets FABP5-mediated ferroptosis to promote proliferation and cisplatin resistance of HNSCC","volume":"27","author":"Qian","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7150\/thno.44868","article-title":"FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.85285","article-title":"FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression","volume":"19","author":"Ye","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2524","article-title":"Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587","volume":"77","author":"Figueroa","year":"2017","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41419-022-04506-4","article-title":"Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.01.046","article-title":"Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment","volume":"30","author":"Xu","year":"2022","journal-title":"Mol Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.09.018","article-title":"FABP5 as a novel molecular target in prostate cancer","author":"O\u2019Sullivan","year":"2020","journal-title":"Drug Discov Today"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002548","article-title":"S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation","volume":"9","author":"Liu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad082","article-title":"Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor \u03b1 and fundamentally changing lipid metabolism","volume":"119","author":"Cao","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41419-023-06383-x","article-title":"TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c09190","article-title":"Tumor microenvironment-derived exosomes: A double-edged sword for advanced T cell-based immunotherapy","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"key":"B32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-019-0772-z","article-title":"Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment","volume":"12","author":"Tian","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz6314","article-title":"Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"Sci Transl Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"111668","DOI":"10.1016\/j.celrep.2022.111668","article-title":"FABP5 controls macrophage alternative activation and allergic asthma by selectively programming long-chain unsaturated fatty acid metabolism","volume":"41","author":"Hou","year":"2022","journal-title":"Cell Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1644645\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:35:55Z","timestamp":1758000955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1644645\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2025.1644645"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1644645","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1644645.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"article-number":"1644645"}}